$114.55+2.63 (+2.35%)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.
Addus HomeCare Corporation in the Healthcare sector is trading at $114.55 with a market capitalization of $1.8B. Wall Street consensus targets $133.00 (13 analysts), implying a +16.1% move over the next 12 months. The stock is currently 8% below its 52-week high of $124.44, remaining 8.7% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $363.61M↓ | $373.08M↑ | $362.30M↑ | $349.44M↑ | $337.71M |
| Gross Profit | $115.87M↓ | $123.61M↑ | $116.72M↑ | $113.88M↑ | $107.68M |
| Operating Income | $34.07M↓ | $42.28M↑ | $32.94M↑ | $32.89M↑ | $30.51M |
| Net Income | $25.07M↓ | $29.78M↑ | $22.85M↑ | $22.05M↑ | $21.23M |
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company op...
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Addus HomeCare Corporation (NASDAQ:ADUS) is one of the best small cap stocks to buy with the highest upside potential. Barclays lifted the price target on Addus HomeCare Corporation (NASDAQ:ADUS) to $96 from $92 on July 8 and maintained an Underweight rating on the shares. The firm adjusted price targets among its U.S. healthcare facilities and managed […]
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how senior health, home health & hospice stocks fared in Q1, starting with Addus HomeCare (NASDAQ:ADUS).
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 6.4% over the past six months, almost identical to the S&P 500.